Outcomes of Cyanoacrylate Tissue Adhesive Application in Corneal Thinning and Perforation.
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
14
3
2019
medline:
18
6
2019
entrez:
14
3
2019
Statut:
ppublish
Résumé
To report the outcomes of cyanoacrylate tissue adhesive (CTA) application in corneal thinning and perforation. A retrospective interventional case series of 137 patients receiving CTA for corneal thinning and perforation in 140 eyes between 2001 and 2018 at a single center was reviewed. Success rate and factors associated with glue failure were analyzed. Median age of the cohort was 63 years and 69 (50%) were women. One hundred fifteen patients (84%) had at least 1 systemic condition, 46 (34%) had autoimmune diseases. Eighty-nine eyes (64%) presented with perforation and 51 (36%) with thinning. The perforation/thinning was central/paracentral in 82 eyes (59%) and peripheral in 57 eyes (41%). Median size of perforation was 3.1 mm. Causes of perforation and thinning were microbial infection in 75 (55%), sterile melt in 49 (35%), laceration in 10, and keratoprosthesis melt in 8 eyes. Median glue retention was 58 days. Success rate of glue application (defined as intact globe without surgical intervention) was 72%, 61%, and 46% at 10, 30, and 90 days after glue application, respectively. Larger size of perforation/thinning, perforation (vs. thinning), and single glue application (vs. multiple) were correlated with higher failure rate. Systemic conditions, use of topical corticosteroid, etiologies, and location of perforation/thinning were not significantly correlated with glue failure. CTA application was moderately effective in stabilizing corneal perforation and thinning in the very short-term. Multiple applications are often required. Maintenance of globe integrity after glue application decreases with time and the need for surgical intervention remains high.
Identifiants
pubmed: 30865049
doi: 10.1097/ICO.0000000000001919
pmc: PMC6517072
mid: NIHMS1519627
doi:
Substances chimiques
Cyanoacrylates
0
Tissue Adhesives
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
668-673Subventions
Organisme : NEI NIH HHS
ID : K12 EY016335
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Cornea. 2000 May;19(3):313-9
pubmed: 10832690
Ophthalmology. 2003 Feb;110(2):291-8
pubmed: 12578769
Cornea. 2003 Jul;22(5):405-8
pubmed: 12827043
J Cataract Refract Surg. 2004 Feb;30(2):287-90
pubmed: 15030802
Cornea. 2006 Apr;25(3):350-1
pubmed: 16633038
Ocul Surf. 2006 Jul;4(3):146-54
pubmed: 16900270
Cornea. 2007 Dec;26(10):1228-34
pubmed: 18043181
Expert Rev Med Devices. 2008 Jan;5(1):41-9
pubmed: 18095895
Am J Ophthalmol. 1991 Apr 15;111(4):466-72
pubmed: 2012149
Cornea. 2010 Sep;29(9):971-5
pubmed: 20539218
Cornea. 2010 Oct;29(10):1173-5
pubmed: 20622669
Cornea. 2012 Apr;31(4):465-6; author reply 466
pubmed: 21857507
Surv Ophthalmol. 2011 Nov-Dec;56(6):522-38
pubmed: 22117886
Cornea. 2013 May;32(5):e137-8
pubmed: 23407321
Cont Lens Anterior Eye. 2013 Aug;36(4):156-8
pubmed: 23623338
JAMA Ophthalmol. 2013 Apr;131(4):422-9
pubmed: 23710492
Am J Ophthalmol. 2014 Feb;157(2):327-333.e3
pubmed: 24315294
Clin Exp Ophthalmol. 2014 Nov;42(8):791-3
pubmed: 24533666
Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25
pubmed: 26545825
Surv Ophthalmol. 1989 Jul-Aug;34(1):47-58
pubmed: 2678553
Br J Ophthalmol. 2017 May;101(5):634-639
pubmed: 27503392
Acta Biomater. 2018 Mar 15;69:31-41
pubmed: 29374600
Br J Ophthalmol. 2018 Oct;102(10):1328-1335
pubmed: 29581352
Am J Ophthalmol. 1987 Oct 15;104(4):437-8
pubmed: 3661662
Am J Ophthalmol. 1971 Sep;72(3):538-41
pubmed: 4936227
Arch Ophthalmol. 1968 Dec;80(6):705-9
pubmed: 5699321
Ophthalmology. 1983 Jun;90(6):610-5
pubmed: 6888854
Ophthalmology. 1994 Dec;101(12):1871-82
pubmed: 7997323
Ophthalmology. 1993 Feb;100(2):173-80
pubmed: 8437823
Doc Ophthalmol. 1996-1997;93(3):237-45
pubmed: 9550352
N Engl J Med. 1998 Jul 30;339(5):300-6
pubmed: 9696640